| Stage | FLXS | % of rev | PNRG | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $98M | 100.00% | $42M | 100.00% | FLXS ×2.33 |
| Gross profit | $20M | 20.16% | $41M | 96.68% | PNRG +76.5pp |
| Operating income | $14M | 13.91% | $8M | 19.59% | PNRG +5.7pp |
| Pre-tax income | $13M | 13.41% | $8M | 18.95% | PNRG +5.5pp |
| Net income | $10M | 10.09% | $7M | 15.44% | PNRG +5.4pp |
| Stage | FLXS | PNRG | Gap · A − B |
|---|---|---|---|
| Revenue | $98M100.00% | $42M100.00% | FLXS ×2.33 |
| Gross profit | 20.16%$20M | 96.68%$41M | PNRG +76.5pp |
| Operating income | 13.91%$14M | 19.59%$8M | PNRG +5.7pp |
| Pre-tax income | 13.41%$13M | 18.95%$8M | PNRG +5.5pp |
| Net income |
| 10.09%$10M |
| 15.44%$7M |
| PNRG +5.4pp |
None
No disclosed counterparties: FLXS.